43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 12
00:54 UTC
|
MDLN
Medline
|
◎ Target | Stephen Baxter ★★★☆☆ #1506 | Equal Weight | $45.00→ $34.00-24.4% |
|
Aug 12
00:54 UTC
|
MDB
MongoDB
|
◎ Target | Tyler Radke ★★★☆☆ #1614 | Buy | $455.00→ $545.00+19.8% |
|
Aug 12
00:54 UTC
|
MCK
McKesson
|
◎ Target | Stephen Baxter ★★★☆☆ #1506 | Equal Weight | $812.00→ $933.00+14.9% |
|
Aug 12
00:54 UTC
|
MAC
Macerich
|
◎ Target | Nick Joseph not yet tracked | Buy | $28.00→ $29.00+3.6% |
|
Aug 12
00:54 UTC
|
LUMN
Lumen Technologies
|
◎ Target | Michael Rollins ★★★☆☆ #1858 | Neutral | $10.00→ $8.25-17.5% |
|
Aug 12
00:54 UTC
|
LOW
Lowe's Companies
|
◎ Target | Zachary Fadem ★★★☆☆ #1918 | Overweight | $255.00→ $245.00-3.9% |
|
Aug 12
00:54 UTC
|
LNG
Cheniere Energy
|
◎ Target | Jason Gabelman ★★★☆☆ #1821 | Buy | $280.00→ $290.00+3.6% |
|
Aug 12
00:54 UTC
|
LKFT
Lakefront Biotherapeutics American Depositary Shares
|
◎ Target | Judah Frommer ★★☆☆☆ #2534 | Equal Weight | $30.00→ $26.00-13.3% |
|
Aug 12
00:54 UTC
|
LKFT
Lakefront Biotherapeutics American Depositary Shares
|
◎ Target | Brian Abrahams ★★☆☆☆ #2650 | Sec→ r Perform | $28.00→ $26.00-7.1% |
|
Aug 12
00:54 UTC
|
LINC
Lincoln Educational Services
|
◎ Target | Steve Frankel ★★☆☆☆ #2659 | Buy | $60.00→ $50.00-16.7% |
|
Aug 12
00:54 UTC
|
LINC
Lincoln Educational Services
|
◎ Target | Eric Martinuzzi ★★★★☆ #593 | Buy | $55.00→ $50.00-9.1% |
|
Aug 12
00:54 UTC
|
LIF
Life360
|
◎ Target | Stephen Ju ★★★☆☆ #1714 | Buy | $64.00→ $60.00-6.2% |
|
Aug 12
00:54 UTC
|
LIF
Life360
|
◎ Target | Wyatt Swanson ★★☆☆☆ #2792 | Neutral | $42.00→ $47.00+11.9% |
|
Aug 12
00:54 UTC
|
LGEN
Legal & General Group
|
◎ Target | firm only | Underperform | GBX 255→ GBX 270+5.9% |
|
Aug 12
00:54 UTC
|
LDOS
Leidos
|
◎ Target | John Godyn ★★★☆☆ #1956 | Buy | $138.00→ $161.00+16.7% |
|
Aug 12
00:54 UTC
|
KVUE
Kenvue
|
◎ Target | Peter Grom ★★★☆☆ #1656 | Neutral | $20.00→ $19.00-5.0% |
|
Aug 12
00:54 UTC
|
KMT
Kennametal
|
◎ Target | Chris Dankert ★★★☆☆ #1866 | Neutral | $34.00→ $30.00-11.8% |
|
Aug 12
00:54 UTC
|
KGS
Kodiak Gas Services
|
◎ Target | Stephen Gengaro ★★☆☆☆ #2382 | Buy | $90.00→ $92.00+2.2% |
|
Aug 12
00:54 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Jeffrey Hung not yet tracked | Overweight | $280.00→ $283.00+1.1% |
|
Aug 12
00:54 UTC
|
ITT
ITT
|
◎ Target | Matt Summerville ★★★☆☆ #1933 | Buy | $255.00→ $265.00+3.9% |
|
Aug 12
00:54 UTC
|
IPGP
IPG Photonics
|
◎ Target | Jamie Wang ★★★★☆ #803 | Buy | $150.00→ $137.00-8.7% |
|
Aug 12
00:54 UTC
|
INVX
Innovex International
|
◎ Target | Eddie Kim ★★★☆☆ #2168 | Equal Weight | $26.00→ $27.00+3.8% |
|
Aug 12
00:54 UTC
|
INTU
Intuit
|
◎ Target | Jared Levine ★★☆☆☆ #2474 | Hold | $304.00→ $328.00+7.9% |
|
Aug 12
00:54 UTC
|
INTR
Inter & Co. Inc.
|
◎ Target | firm only | Buy | $9.40→ $8.80-6.4% |
|
Aug 12
00:54 UTC
|
IMMX
Immix Biopharma
|
◎ Target | Judah Frommer ★★☆☆☆ #2534 | Overweight | $20.00→ $19.00-5.0% |
|
Aug 12
00:54 UTC
|
IHP
IntegraFin
|
◎ Target | firm only | Buy | GBX 475→ GBX 490+3.2% |
|
Aug 12
00:54 UTC
|
IDXX
IDEXX Laboratories
|
◎ Target | Glen Santangelo ★★★☆☆ #1453 | Overweight | $800.00→ $710.00-11.2% |
|
Aug 12
00:54 UTC
|
HST
Host Hotels & Resorts
|
◎ Target | Jay Kornreich ★★★★☆ #852 | Neutral | $23.00→ $24.00+4.3% |
|
Aug 12
00:54 UTC
|
HQI
HireQuest
|
◎ Target | Michael Baker ★★★☆☆ #1111 | Buy | $15.00→ $19.00+26.7% |
|
Aug 12
00:54 UTC
|
HLT
Hilton Worldwide
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1137 | Neutral | $353.00→ $345.00-2.3% |
|
Aug 12
00:54 UTC
|
HLN
Haleon
|
◎ Target | firm only | Sec→ r perform | GBX 370→ GBX 390+5.4% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Jonna Kim ★★★☆☆ #974 | Hold | $25.00→ $30.00+20.0% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | George Hill ★★★★★ #278 | Hold | $25.00→ $26.00+4.0% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Craig Hettenbach ★★★☆☆ #1929 | Equal Weight | $21.00→ $28.00+33.3% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Daniel Grosslight ★★★★☆ #912 | Neutral | $35.00→ $33.00-5.7% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Allen Lutz ★★☆☆☆ #2504 | Neutral | $30.00→ $32.00+6.7% |
|
Aug 12
00:54 UTC
|
HIMS
Hims & Hers Health
|
◎ Target | Ryan MacDonald ★★★☆☆ #1376 | Buy | $35.00→ $42.00+20.0% |
|
Aug 12
00:54 UTC
|
HIK
Hikma Pharmaceuticals
|
◎ Target | firm only | Buy | GBX 1,800→ GBX 2,100+16.7% |
|
Aug 12
00:54 UTC
|
HGTY
Hagerty
|
◎ Target | Thomas McJoynt-Griffith not yet tracked | Outperform | $15.00→ $16.00+6.7% |
|
Aug 12
00:54 UTC
|
HE
Hawaiian Electric Industries
|
◎ Target | Nicholas Campanella ★★★★☆ #930 | Equal Weight | $13.00→ $12.00-7.7% |
|
Aug 12
00:54 UTC
|
HD
Home Depot
|
◎ Target | Zachary Fadem ★★★☆☆ #1918 | Overweight | $360.00→ $400.00+11.1% |
|
Aug 12
00:54 UTC
|
HCAT
Health Catalyst
|
◎ Target | Daniel Grosslight ★★★★☆ #912 | Neutral | $2.50→ $2.00-20.0% |
|
Aug 12
00:54 UTC
|
HBT
HBT Financial
|
◎ Target | Jeff Rulis ★★★★★ #316 | Neutral | $36.00→ $38.00+5.6% |
|
Aug 12
00:54 UTC
|
H
Hyatt Hotels
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1137 | Neutral | $180.00→ $185.00+2.8% |
|
Aug 12
00:54 UTC
|
GWW
W.W. Grainger
|
◎ Target | Guy Hardwick ★★★☆☆ #2139 | Underweight | $1,166.00→ $1,185.00+1.6% |
|
Aug 12
00:54 UTC
|
GDRX
GoodRx
|
◎ Target | Charles Rhyee ★★★☆☆ #1300 | Buy | $4.00→ $5.00+25.0% |
|
Aug 12
00:54 UTC
|
GDRX
GoodRx
|
◎ Target | Daniel Grosslight ★★★★☆ #912 | Buy | $4.00→ $5.00+25.0% |
|
Aug 12
00:54 UTC
|
GCMG
GCM Grosvenor
|
◎ Target | Crispin Love ★★★☆☆ #1445 | Overweight | $15.00→ $16.00+6.7% |
|
Aug 12
00:54 UTC
|
GCMG
GCM Grosvenor
|
◎ Target | Kenneth Worthington not yet tracked | Neutral | $12.00→ $13.00+8.3% |
|
Aug 12
00:54 UTC
|
FUN
Six Flags Entertainment
|
◎ Target | Matthew Boss ★★★☆☆ #1257 | Neutral | $26.00→ $22.00-15.4% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.